The malaria diagnostics market is expected to touch USD 0.82 billion by 2032, growing at 5.7% from 2023 to 2032. Many variables shape the Malaria Diagnostics Market and drive its development. Infected mosquitoes spread Plasmodium parasite-caused malaria, a lethal disease. The worldwide malaria load is a major factor. Malaria detection technologies must be accurate and fast for disease management, treatment, and prevention. Malaria continues to affect endemic communities; thus precise and fast diagnostic technologies are needed.
Rapid diagnostic tests (RDTs), molecular diagnostics, and microscopy advances make diagnostic equipment more sensitive, specific, and user-friendly. Point-of-care testing and new technologies like nucleic acid amplification and biosensors have increased malaria detection speed and accuracy. This is especially true in resource-poor, disease-endemic areas.
The World Health Organization (WHO) and the Roll Back Malaria Partnership are leading malaria control efforts that emphasize the need of precise diagnosis. In nations with the illness, governments typically start mass screening and treatment programs, increasing the demand for inexpensive and scalable diagnostic options. Regulatory frameworks and quality assurance are essential for malaria diagnostic technology reliability and efficacy.
Due to drug-resistant strains and fluctuating transmission patterns, malaria epidemiology demands flexible diagnostic tools. The diagnostic equipment must detect P. falciparum, the deadliest Plasmodium species, and P. vivax, another frequent parasite. The invention and implementation of malaria diagnostics need the flexibility to distinguish between species and assess drug resistance trends to identify effective treatment options.
In low-resource areas, pricey diagnostic technology may be hard to acquire and utilize. Decentralized and community-level testing requires fast, cost-effective diagnostic procedures like quick diagnostic tests. These diagnostic technologies reach malaria-stricken regions thanks to donor money, global collaborations, and government subsidies.
Major factors affecting the Malaria Diagnostics Market are competition and consolidation. Established diagnostic companies, new competitors, and strategic collaborations make the industry competitive. Diagnostic companies may expand their market presence and product distribution by partnering with governments, NGOs, and international agencies. Competitive dynamics affect malaria diagnostic equipment availability, product development, and cost.
Report Attribute/Metric | Details |
---|
Malaria Diagnostics Market Segmentation
The malaria diagnostics market has been segmented on the basis of technology and end-user.
On the basis of technology, the market has been classified as rapid diagnostic tests, microscopy, and molecular diagnostic tests. The molecular diagnostics tests are segmented into polymerase chain reaction (PCR) and real-time polymerase chain reaction (RT-PCR).
On the basis of end-users, the market has been classified as hospitals, clinics, community healthcare, and others.
On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.
The European malaria diagnostics market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.Â
The malaria diagnostics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The malaria diagnostics market in the Middle East and Africa has been segmented into the Middle East and Africa.Â
Regional Market Summary
Global Malaria Diagnostics Share, by Region, 2017 (%)
Source: MRFR Analysis
In the malaria diagnostics market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies, the rise in awareness, the rise in growth of the healthcare sector, and due to favorable compensation setting for many surgical procedures. In 2016, global governments of malaria-endemic countries have invested USD 2.7 billion in malaria control and elimination efforts. The US was the largest contributor by providing USD 1 billion for the eradication of malaria.
The European market is expected to hold the least share due to the growing number of malaria-free countries in the region.
The market share in Asia-Pacific is also projected to experience growth in the near future due to access to optimal treatment facilities and growing demand for advanced technology, better adoption rate, increase in disposable income, and rising medical tourism. The Asia-Pacific remains to be the second largest burden of malaria globally with 22 malaria-endemic countries accounting for roughly 28 million cases and 45,000 deaths every year. The WHO figures say that in the Asia-Pacific region, Myanmar, Pakistan, India, and Indonesia carry the highest malaria burden accounting for 89% of all malaria cases in the region.
The market in the Middle East and Africa is expected to account for the smallest share of the global malaria diagnostics market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities. Sub-Saharan Africa remains to bring an excessively high share of the global malaria burden on the Middle Eastern and African market. the region was home to 90% of malaria incidences and 92% of malaria deaths in 2015
Malaria Diagnostics Market Key Players
Some of the key players in the global malaria diagnostics market are Access Bio. Inc., Abbott Laboratories, Premier Medical Corporation Pvt. Ltd, Sysmex Partec GmbH, bioMérieux, Beckman Coulter Inc., Siemens Healthineers, Leica Microsystems GmbH, Nikon Corporation, Olympus Corporation, and Bio-Rad Laboratories Inc.Recent Development
Global Malaria Diagnostics Market, by Technique
Global Malaria Diagnostics Market, by End-Users
Global Malaria Diagnostics Market, by Region
Americas
Europe
Asia-Pacific
Middle East & Africa
Intended Audience
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)